BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9776495)

  • 21. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C; Wittchen F; Suckau L; Witt H; Noutsias M; Fechner H; Schultheiss HP; Poller W
    Eur Heart J; 2008 May; 29(9):1168-80. PubMed ID: 18390538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
    Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M
    Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.
    Yasue H; Obata K; Okumura K; Kurose M; Ogawa H; Matsuyama K; Jougasaki M; Saito Y; Nakao K; Imura H
    J Clin Invest; 1989 Jan; 83(1):46-51. PubMed ID: 2521343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.
    Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ
    Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
    Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
    Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure].
    Oldenburg O; Lamp B; Töpfer V; Faber L; Teschler H; Horstkotte D
    Dtsch Med Wochenschr; 2007 Mar; 132(13):661-6. PubMed ID: 17377879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases.
    Dzimiri N; Muiya P; Andres E; Al-Halees Z
    Eur J Pharmacol; 2004 Apr; 489(3):167-77. PubMed ID: 15087239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart.
    Serneri GG; Cecioni I; Vanni S; Paniccia R; Bandinelli B; Vetere A; Janming X; Bertolozzi I; Boddi M; Lisi GF; Sani G; Modesti PA
    Circ Res; 2000 Mar; 86(4):377-85. PubMed ID: 10700441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
    Tarazón E; Roselló-Lletí E; Rivera M; Ortega A; Molina-Navarro MM; Triviño JC; Lago F; González-Juanatey JR; Orosa P; Montero JA; Salvador A; Portolés M
    PLoS One; 2014; 9(3):e90157. PubMed ID: 24599027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart.
    Dieterich S; Bieligk U; Beulich K; Hasenfuss G; Prestle J
    Circulation; 2000 Jan 4-11; 101(1):33-9. PubMed ID: 10618301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.
    Herpel E; Singer S; Flechtenmacher C; Pritsch M; Sack FU; Hagl S; Katus HA; Haass M; Otto HF; Schnabel PA
    Virchows Arch; 2005 Apr; 446(4):369-78. PubMed ID: 15806380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure.
    Böhm M; Eschenhagen T; Gierschik P; Larisch K; Lensche H; Mende U; Schmitz W; Schnabel P; Scholz H; Steinfath M
    J Mol Cell Cardiol; 1994 Feb; 26(2):133-49. PubMed ID: 8006975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
    Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
    J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy.
    Fonfara S; Hetzel U; Oyama MA; Kipar A
    Vet J; 2014 Mar; 199(3):406-12. PubMed ID: 24440442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.
    Westphal E; Rohrbach S; Buerke M; Behr H; Darmer D; Silber RE; Werdan K; Loppnow H
    Mol Med; 2008; 14(1-2):55-63. PubMed ID: 17948066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM).
    Ukimura A; Terasaki F; Fujioka S; Deguchi H; Kitaura Y; Isomura T; Suma H
    J Card Surg; 2003; 18 Suppl 2():S101-8. PubMed ID: 12930277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins.
    Mándi Y; Hogye M; Talha EM; Skolák E; Csanády M
    Pathobiology; 2000; 68(3):150-8. PubMed ID: 11174073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy.
    Spänig S; Kellermann K; Dieterlen MT; Noack T; Lehmann S; Borger MA; Garbade J; Barac YD; Emrich F
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.